JNJ
Johnson & Johnson
NYSE: JNJ · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$229.85
+1.10% today
Updated 2026-04-29
Market cap
$547.28B
P/E ratio
26.31
P/S ratio
5.68x
EPS (TTM)
$8.64
Dividend yield
2.28%
52W range
$142 – $252
Volume
8.0M
Johnson & Johnson (JNJ) Insider transactions
Net insider activity
Net buying (160,503 shares)
Buy transactions
44
Sell transactions
56
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-10 | WOODS, EUGENE A. | Director | Buy | 155 | $242.14 | $37531.70 |
| 2026-03-10 | PINTO, DANIEL E | Director | Buy | 129 | $242.14 | $31236.06 |
| 2026-03-10 | HEWSON, MARILLYN A | Director | Buy | 206 | $242.14 | $49880.84 |
| 2026-02-27 | DECKER, ROBERT J | VP Corporate Controller | Sale | 4,075 | — | — |
| 2026-02-27 | DECKER, ROBERT J | VP Corporate Controller | Buy | 4,075 | $115.67 | $471355.25 |
| 2026-02-20 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Sale | 1,322 | $245.66 | $324762.52 |
| 2026-02-18 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Sale | 13,625 | — | — |
| 2026-02-18 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Sale | 8,998 | — | — |
| 2026-02-18 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Buy | 13,625 | $115.67 | $1.58M |
| 2026-02-18 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Buy | 8,998 | $129.51 | $1.17M |
| 2026-02-17 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 33,386 | — | — |
| 2026-02-17 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 19,241 | — | — |
| 2026-02-17 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 12,066 | — | — |
| 2026-02-17 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 33,386 | $242.75 | $8.10M |
| 2026-02-17 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 24,961 | $242.68 | $6.06M |
| 2026-02-17 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 19,241 | $242.99 | $4.68M |
| 2026-02-17 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 12,066 | $242.87 | $2.93M |
| 2026-02-17 | SWANSON, JAMES D. | EVP, CIO | Sale | 20,521 | — | — |
| 2026-02-17 | SWANSON, JAMES D. | EVP, CIO | Buy | 20,521 | $164.62 | $3.38M |
| 2026-02-17 | REED, JOHN C | EVP, Innovative Medicine, R&D | Sale | 29,927 | — | — |
| 2026-02-17 | REED, JOHN C | EVP, Innovative Medicine, R&D | Sale | 21,721 | — | — |
| 2026-02-17 | REED, JOHN C | EVP, Innovative Medicine, R&D | Sale | 29,927 | $243.00 | $7.27M |
| 2026-02-17 | REED, JOHN C | EVP, Innovative Medicine, R&D | Sale | 21,721 | $243.00 | $5.28M |
| 2026-02-17 | REED, JOHN C | EVP, Innovative Medicine, R&D | Sale | 2,283 | $243.00 | $554769.00 |
| 2026-02-17 | BROADHURST, VANESSA | EVP, Global Corp Affairs | Sale | 6,197 | $243.39 | $1.51M |
| 2026-02-15 | WOLK, JOSEPH J | Exec VP, CFO | Buy | 3,863 | — | — |
| 2026-02-15 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 1,971 | — | — |
| 2026-02-15 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 1,878 | — | — |
| 2026-02-15 | WOLK, JOSEPH J | Exec VP, CFO | Buy | 53,793 | — | — |
| 2026-02-15 | WOLK, JOSEPH J | Exec VP, CFO | Buy | 1,971 | — | — |
| 2026-02-15 | WOLK, JOSEPH J | Exec VP, CFO | Buy | 1,878 | — | — |
| 2026-02-15 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 858 | $243.45 | $208880.10 |
| 2026-02-15 | WOLK, JOSEPH J | Exec VP, CFO | Sale | 817 | $243.45 | $198898.65 |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | Buy | 1,217 | — | — |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | Sale | 635 | — | — |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | Sale | 606 | — | — |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | Buy | 16,945 | — | — |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | Buy | 635 | — | — |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | Buy | 606 | — | — |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | Sale | 325 | $243.45 | $79121.25 |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | Sale | 310 | $243.45 | $75469.50 |
| 2026-02-15 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | Buy | 3,940 | — | — |
| 2026-02-15 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | Sale | 1,847 | — | — |
| 2026-02-15 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | Sale | 1,594 | — | — |
| 2026-02-15 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | Buy | 54,869 | — | — |
| 2026-02-15 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | Buy | 1,847 | — | — |
| 2026-02-15 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | Buy | 1,594 | — | — |
| 2026-02-15 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | Sale | 945 | $243.45 | $230060.25 |
| 2026-02-15 | TAUBERT, JENNIFER L | EVP, WWC. Innovative Medicine | Sale | 816 | $243.45 | $198655.20 |
| 2026-02-15 | SWANSON, JAMES D. | EVP, CIO | Buy | 1,397 | — | — |
| 2026-02-15 | SWANSON, JAMES D. | EVP, CIO | Sale | 709 | — | — |
| 2026-02-15 | SWANSON, JAMES D. | EVP, CIO | Sale | 492 | — | — |
| 2026-02-15 | SWANSON, JAMES D. | EVP, CIO | Buy | 19,449 | — | — |
| 2026-02-15 | SWANSON, JAMES D. | EVP, CIO | Buy | 709 | — | — |
| 2026-02-15 | SWANSON, JAMES D. | EVP, CIO | Buy | 492 | — | — |
| 2026-02-15 | SWANSON, JAMES D. | EVP, CIO | Sale | 309 | $243.45 | $75226.05 |
| 2026-02-15 | SWANSON, JAMES D. | EVP, CIO | Sale | 214 | $243.45 | $52098.30 |
| 2026-02-15 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Buy | 2,548 | — | — |
| 2026-02-15 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Sale | 1,028 | — | — |
| 2026-02-15 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Sale | 1,026 | — | — |
| 2026-02-15 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Buy | 35,489 | — | — |
| 2026-02-15 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Buy | 1,028 | — | — |
| 2026-02-15 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Buy | 1,026 | — | — |
| 2026-02-15 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Sale | 448 | $243.45 | $109065.60 |
| 2026-02-15 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | Sale | 15 | $243.45 | $3651.75 |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | Buy | 3,546 | — | — |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | Sale | 1,847 | — | — |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | Sale | 1,349 | — | — |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | Buy | 49,382 | — | — |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | Buy | 1,847 | — | — |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | Buy | 1,349 | — | — |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | Sale | 528 | $243.45 | $128541.60 |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | Sale | 385 | $243.45 | $93728.25 |
| 2026-02-15 | MULHOLLAND, KRISTEN | EVP, Chief HR Officer | Buy | 1,459 | — | — |
| 2026-02-15 | MULHOLLAND, KRISTEN | EVP, Chief HR Officer | Sale | 575 | — | — |
| 2026-02-15 | MULHOLLAND, KRISTEN | EVP, Chief HR Officer | Sale | 419 | — | — |
| 2026-02-15 | MULHOLLAND, KRISTEN | EVP, Chief HR Officer | Buy | 20,322 | — | — |
| 2026-02-15 | MULHOLLAND, KRISTEN | EVP, Chief HR Officer | Buy | 575 | — | — |
| 2026-02-15 | MULHOLLAND, KRISTEN | EVP, Chief HR Officer | Buy | 419 | — | — |
| 2026-02-15 | MULHOLLAND, KRISTEN | EVP, Chief HR Officer | Sale | 251 | $243.45 | $61105.95 |
| 2026-02-15 | MULHOLLAND, KRISTEN | EVP, Chief HR Officer | Sale | 172 | $243.45 | $41873.40 |
| 2026-02-15 | FORMINARD, ELIZABETH | EVP, Chief Legal Officer | Buy | 1,944 | — | — |
| 2026-02-15 | FORMINARD, ELIZABETH | EVP, Chief Legal Officer | Sale | 1,063 | — | — |
| 2026-02-15 | FORMINARD, ELIZABETH | EVP, Chief Legal Officer | Sale | 961 | — | — |
| 2026-02-15 | FORMINARD, ELIZABETH | EVP, Chief Legal Officer | Buy | 27,076 | — | — |
| 2026-02-15 | FORMINARD, ELIZABETH | EVP, Chief Legal Officer | Buy | 1,063 | — | — |
| 2026-02-15 | FORMINARD, ELIZABETH | EVP, Chief Legal Officer | Buy | 961 | — | — |
| 2026-02-15 | FORMINARD, ELIZABETH | EVP, Chief Legal Officer | Sale | 544 | $243.45 | $132436.80 |
| 2026-02-15 | FORMINARD, ELIZABETH | EVP, Chief Legal Officer | Sale | 492 | $243.45 | $119777.40 |
| 2026-02-15 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | Buy | 9,459 | — | — |
| 2026-02-15 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | Sale | 4,505 | — | — |
| 2026-02-15 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | Sale | 3,682 | — | — |
| 2026-02-15 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | Buy | 131,734 | — | — |
| 2026-02-15 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | Buy | 4,505 | — | — |
| 2026-02-15 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | Buy | 3,682 | — | — |
| 2026-02-15 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | Sale | 1,960 | $243.45 | $477162.00 |
| 2026-02-15 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | Sale | 1,602 | $243.45 | $390006.90 |
| 2026-02-15 | DECKER, ROBERT J | VP Corporate Controller | Buy | 700 | — | — |
| 2026-02-15 | DECKER, ROBERT J | VP Corporate Controller | Sale | 344 | — | — |
| 2026-02-15 | DECKER, ROBERT J | VP Corporate Controller | Sale | 339 | — | — |